Ayub S, Bachu A, Jain L, Parnia S, Bhivandkar S, Ahmed R
Front Pain Res (Lausanne). 2024; 5:1398442.
PMID: 39449766
PMC: 11499177.
DOI: 10.3389/fpain.2024.1398442.
Jain J, Heise M, Lisha N, Moreira C, Glidden D, Burkholder G
Open Forum Infect Dis. 2024; 11(9):ofae491.
PMID: 39252870
PMC: 11382144.
DOI: 10.1093/ofid/ofae491.
Prahlow J, Jones P, Bailey K, Grande A, Obead A, Pink C
Acad Forensic Pathol. 2024; 14(3):87-107.
PMID: 39246388
PMC: 11380442.
DOI: 10.1177/19253621231224532.
Fraser H, Stone J, Facente S, Artenie A, Patel S, Wilson E
Int J Drug Policy. 2024; 131:104452.
PMID: 38910096
PMC: 7617003.
DOI: 10.1016/j.drugpo.2024.104452.
Brown C, Johnson K, Hills H, Vermeer W, Clarke D, Barnett J
Front Public Health. 2024; 12:1366161.
PMID: 38859894
PMC: 11163089.
DOI: 10.3389/fpubh.2024.1366161.
State COVID-19 Policies and Drug Overdose Mortality Among Working-Age Adults in the United States, 2020.
Wolf D, Monnat S, Wiemers E, Sun Y, Zhang X, Grossman E
Am J Public Health. 2024; 114(7):714-722.
PMID: 38696735
PMC: 11153954.
DOI: 10.2105/AJPH.2024.307621.
"Whatever journey you want to take, I'll support you through": a mixed methods evaluation of a peer worker program in the hospital emergency department.
ONeill M, Michalski C, Hayman K, Hulme J, Dube S, Diemert L
BMC Health Serv Res. 2024; 24(1):147.
PMID: 38287378
PMC: 10826204.
DOI: 10.1186/s12913-023-10532-5.
Enhancing Protective Antibodies against Opioids through Antigen Display on Virus-like Particles.
Shafieichaharberoud F, Lang S, Whalen C, Rivera Quiles C, Purcell L, Talbot C
Bioconjug Chem. 2023; 35(2):164-173.
PMID: 38113481
PMC: 11259974.
DOI: 10.1021/acs.bioconjchem.3c00415.
COVID-19 pandemic impact on opioid overdose deaths among racial groups within the United States: an observational cross-sectional study.
Chu R, Sarnala S, Doan T, Cheng T, Chen A, Jamal A
Br J Anaesth. 2023; 132(1):201-204.
PMID: 37977954
PMC: 11220372.
DOI: 10.1016/j.bja.2023.10.024.
Redesign of Opioid Use Disorder Screening and Treatment in the ED.
Lowenstein M, McFadden R, Abdel-Rahman D, Perrone J, Meisel Z, ODonnell N
NEJM Catal Innov Care Deliv. 2023; 3(1).
PMID: 37961066
PMC: 10641724.
DOI: 10.1056/CAT.21.0297.
Intersectional Stigma as a Fundamental Cause of Health Disparities: A case study of how drug use stigma intersecting with racism and xenophobia creates health inequities for Black and Hispanic persons who use drugs over time.
Walters S, Kerr J, Cano M, Earnshaw V, Link B
Stigma Health. 2023; 8(3):325-343.
PMID: 37744082
PMC: 10516303.
DOI: 10.1037/sah0000426.
Estimating the uncertain effect of the COVID pandemic on drug overdoses.
Moghtaderi A, Zocchi M, Pines J, Venkat A, Black B
PLoS One. 2023; 18(8):e0281227.
PMID: 37561686
PMC: 10414597.
DOI: 10.1371/journal.pone.0281227.
Opioid and stimulant attributed treatment admissions and fatal overdoses: Using national surveillance data to examine the intersection of race, sex, and polysubstance use, 1992-2020.
Jones A, Shearer R, Segel J, Santos-Lozada A, Strong-Jones S, Vest N
Drug Alcohol Depend. 2023; 249:109946.
PMID: 37354584
PMC: 10375360.
DOI: 10.1016/j.drugalcdep.2023.109946.
Application of The Consolidated Framework for Implementation Research to inform understanding of barriers and facilitators to the implementation of opioid and naloxone training on college campuses.
Shelton R, Goodwin K, McNeil M, Bernitz M, Alexander S, Parish C
Implement Sci Commun. 2023; 4(1):56.
PMID: 37221618
PMC: 10204023.
DOI: 10.1186/s43058-023-00438-y.
A qualitative study of people who use methamphetamine during the early COVID-19 pandemic to inform future ED harm reduction strategies.
Morse S, Fockele C, Huynh L, Zatzick A, Whiteside L
Int J Emerg Med. 2023; 16(1):30.
PMID: 37106338
PMC: 10139825.
DOI: 10.1186/s12245-023-00505-0.
Increases in overdoses during the COVID-19 pandemic.
Shekhar A, Boyd J
Proc (Bayl Univ Med Cent). 2023; 36(3):411-412.
PMID: 37091752
PMC: 10120522.
DOI: 10.1080/08998280.2023.2180256.
"It's just another tool on my toolbelt": New York state law enforcement officer experiences administering naloxone.
Lloyd D, Rowe K, Leung S, Pourtaher E, Gelberg K
Harm Reduct J. 2023; 20(1):29.
PMID: 36879248
PMC: 9987370.
DOI: 10.1186/s12954-023-00748-3.
Immunotherapeutic strategies for treating opioid use disorder and overdose.
Luba R, Martinez S, Jones J, Pravetoni M, Comer S
Expert Opin Investig Drugs. 2023; 32(1):77-87.
PMID: 36696567
PMC: 10035039.
DOI: 10.1080/13543784.2023.2173062.
The effects of the COVID-19 pandemic on drug and poison-related deaths in Gold Coast, Australia.
Thompson I, Olumbe A, Tse R, Thompson M
Forensic Sci Med Pathol. 2022; 19(2):154-159.
PMID: 36400985
PMC: 9676762.
DOI: 10.1007/s12024-022-00555-5.
The Impact of COVID-19 on Opioid-Related Overdose Deaths in Texas.
Lalani K, Bakos-Block C, Cardenas-Turanzas M, Cohen S, Gopal B, Champagne-Langabeer T
Int J Environ Res Public Health. 2022; 19(21).
PMID: 36360676
PMC: 9657935.
DOI: 10.3390/ijerph192113796.
